ID
45826
Beskrivning
Principal Investigator: Andrea H. Bild, PhD, University of Utah, Salt Lake City, UT, USA MeSH: Breast Neoplasms https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001044 We sought to identify genomic variants that differed between individuals who developed familial breast cancer and individuals who had a family history of breast cancer but who had not developed breast cancer. We aggregated these data at the pathway level to identify pathways that play a role in familial breast cancer development. We profiled peripheral blood cells, extracted DNA, and sequenced the DNA using exome-capture sequencing to identify genomic variants in these samples. For 34 of the 35 samples, we also profiled peripheral blood using Affymetrix Human Exon 1.0 ST Array microarrays. Those data can be found in Gene Expression Omnibus under accession identifier GSE47862.
Länk
Nyckelord
Versioner (1)
- 2023-07-29 2023-07-29 - Simon Heim
Rättsinnehavare
Andrea H. Bild, PhD, University of Utah, Salt Lake City, UT, USA
Uppladdad den
29 juli 2023
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
dbGaP phs001044 Breast Cancer Risk Pathways
This sample attributes table contains sample ID, body site where sample was collected, analyte type, tumor status, and histological type.
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent file includes subject ID, consent information, and case control status for breast cancer.
- This data table contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample use.
- This subject phenotype table contains subject ID, whether the subject had developed cancer, age when blood sample was collected, mutated gene, and gene expression identifier.
- This sample attributes table contains sample ID, body site where sample was collected, analyte type, tumor status, and histological type.
Similar models
This sample attributes table contains sample ID, body site where sample was collected, analyte type, tumor status, and histological type.
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent file includes subject ID, consent information, and case control status for breast cancer.
- This data table contains a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample use.
- This subject phenotype table contains subject ID, whether the subject had developed cancer, age when blood sample was collected, mutated gene, and gene expression identifier.
- This sample attributes table contains sample ID, body site where sample was collected, analyte type, tumor status, and histological type.
C1299222 (UMLS CUI [1,2])
C1518422 (UMLS CUI [1,2])
C0007634 (UMLS CUI [1,2])
C0332307 (UMLS CUI [1,3])
C2347026 (UMLS CUI [2,1])
C0007634 (UMLS CUI [2,2])
C0449560 (UMLS CUI [2,3])
C1292533 (UMLS CUI [3,1])
C0332307 (UMLS CUI [3,2])
C1292533 (UMLS CUI [4,1])
C0449560 (UMLS CUI [4,2])